Primary results show improvements in clinical outcomes in TOURMALINE-AL1 phase III study Dec. 27, 2019
Orkedia approved in Japan for hypercalcemia in parathyroid carcinoma or primary hyperparathyroidism Dec. 23, 2019
RSS